Lack of significant inhibitory effects of a plant lignan tracheloside on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary carcinogenesis in female Sprague-Dawley rats

Cancer Letters

Volumn 200, Issue 2, 2003, Pages 133-139

  Kitamura, Yasuki ^a   Yamagishi, Megumi ^a   Okazaki, Kazushi ^a   Son, Hwa Young ^a,b   Imazawa, Takayoshi ^a   Nishikawa, Akiyoshi ^a   Iwata, Toshio ^c   Yamauchi, Yoshie ^c   Kasai, Masaaki ^c   Tsutsumi, Kentaro ^c   Hirose, Masao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b Chungnam National University   (South Korea)

^c Rinoru Oil Mills Co Ltd   (Japan)

Author keywords

2 Amino 1 methyl 6 phenylimidazo 4,5 b pyridine (PhIP); Lignan; Mammary carcinogenesis; Tracheloside

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; CARCINOGEN; LIGNAN; TRACHELOSIDE; UNCLASSIFIED DRUG; 2 AMINO 1 METHYL 6 PHENYLIMIDAZO(4,5 B)PYRIDINE; 2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-B)PYRIDINE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; GLUCOSIDE; IMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER PREVENTION; CANCER SURVIVAL; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET; DRUG EFFECT; DRUG EFFICACY; EXPOSURE; FEMALE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; ANIMAL; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; SPRAGUE DAWLEY RAT;

ANIMALIA; CARTHAMUS; CARTHAMUS TINCTORIUS;

4-BUTYROLACTONE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; FEMALE; GLUCOSIDES; IMIDAZOLES; LIGNANS; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0642365665     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00281-7     Document Type: Article

References (22)

1. Adlercreutz H., Goldin B.R., Gorbach S.I., Hockerstedt K.A., Watanabe S., Hamalainen E.K., Markkanen M.H., Makela T.H., Wahala K.T. Soybean phytoestrogen intake and cancer risk. J. Nutr. 125:(Suppl. 3):1995;757-770.
2. Adlercreutz H. Phytoestrogens and prevention of cancer. Ohigashi H., Osawa T., Terao J., Watanabe S., Yoshikawa T. Food Factors for Cancer Prevention. 1997;587-592 Springer, Berlin.
3. Nose M., Fujimoto T., Takeda T., Nishibe S., Ogihara Y. Structural transformation of lignan compounds in rat gastrointestinal tract. Planta. Med. 58:1992;520-523.
4. Nose M., Fujimoto T., Nishibe S., Ogihara Y. Structural transformation of lignan compounds in rat gastrointestinal tract (II). Planta. Med. 59:1993;131-134.
5. Nishibe S. Bioactive phenolic compounds for cancer prevention from herbal medicines. Ohigashi H., Osawa T., Terao J., Watanabe S., Yoshikawa T. Food Factors for Cancer Prevention. 1997;276-279 Springer, Berlin.
6. Hirano T., Gotoh M., Oka T. Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci. 55:1994;1061-1069.
7. Takasaki M., Konoshima T., Komatsu K., Tokuda H., Nishino H. Anti-tumor-promoting activity of lignans from the aerial part of Saussurea medusa. Cancer Lett. 158:2000;53-59.
8. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 16:1995;39-52.
9. Augustsson K., Skog K., Jägerstad M., Steineck G. Assessment of the human exposure to heterocyclic amines. Carcinogenesis. 18:1997;1931-1935.
10. Wakabayashi K., Nagao M., Esumi H., Sugimura T. Food-derived mutagens and carcinogens. Cancer Res. 52:(Suppl.):1992;2092-2098.
11. Shirai T., Sano M., Tamano S., Takahashi S., Hirose M., Futakuchi M., Hasegawa R., Imaida K., Matsumoto K., Wakabayashi K., Sugimura T., Ito N. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) derived from cooked foods. Cancer Res. 57:1997;195-198.
12. Hirose M., Yamaguchi T., Lin C., Kimoto N., Futakuchi M., Kono T., Nishibe S., Shirai T. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett. 155:2000;79-88.
13. Hirose M., Hoshiya T., Akagi K., Futakuchi M., Ito N. Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pre-treated with 7,12-dimethylbenz(a)anthracene. Cancer Lett. 83:1994;146-149.
14. Tanaka H., Hirose M., Kawabe M., Sano M., Takesada Y., Hagiwara A., Shirai T. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz(a)anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. Cancer Lett. 116:1997;47-52.
15. Ip C., Scimeca J.A. Conjugated linoleic acid and linoleic acid are distinctive modulators of mammary carcinogenesis. Nutr. Cancer. 27:1997;131-135.
16. Kimoto N., Hirose M., Futakuchi M., Iwata T., Kasai M., Shirai T. Site-dependent modulating effects of conjugated fatty acids from safflower oil in a rat two-stage carcinogenesis model in female Sprague-Dawley rats. Cancer Lett. 168:2001;15-21.
17. Thompson L.U., Rickard S.E., Orcheson L.J., Seidl M.M. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis. 17:1996;1373-1376.
18. Saarinen N.M., Warri A., Makela S.I., Eckerman C., Reunanen M., Ahotupa M., Salmi S.M., Franke A.A., Kangas L., Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr. Cancer. 36:2000;207-216.
19. Saarinen N.M., Huovinen R., Warri A., Makela S.I., Valentin-Blasini L., Needham L., Eckerman C., Collan Y.U., Santti R. Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model. Nutr. Cancer. 41:2001;82-90.
20. Wang L.Q. Mammalian phytoestrogens: enterodiol and enterolactone. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777:2002;289-309.
21. Martin M.E., Haourigui M., Pelissero C., Benassayag C., Nunez E.A. Interactions between phytoestrogens and human sex steroid binding protein. Life Sci. 58:1996;429-436.
22. Pfeifer K., Merz H., Steffen R., Müller W.E.G., Trumm S., Schulz J., Eich E., Schröder H.C. In-vitro anti-HIV activity of lignans - differential inhibition of HIV-1 integrase reaction, topoisomerase activity and cellular microtubules. J. Pharm. Med. 2:1992;75-97.